147 related articles for article (PubMed ID: 12460237)
1. Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemia.
Crawford JH; Eikelboom JW; McQuillan A
Eur J Haematol; 2002; 69(5-6):315-7. PubMed ID: 12460237
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced palmer planter erythrodysesthesia.
Bhasin S; Sunita ; Gupta DK; Kataria SP; Saluja S; Sharma M
J Assoc Physicians India; 2005 Feb; 53():155-6. PubMed ID: 15847041
[TBL] [Abstract][Full Text] [Related]
3. Acral erythema with bullous formation: a side effect of chemotherapy in a child with acute lymphoblastic leukemia.
Aytaç S; Gümrük F; Cetin M; Tuncer M; Yetgin S
Turk J Pediatr; 2010; 52(2):211-4. PubMed ID: 20560263
[TBL] [Abstract][Full Text] [Related]
4. [6-mercaptopurine-related hand-foot syndrome in a four-year-old child].
Giacchero D; Monpoux F; Chiavérini C; Lacour JP
Ann Dermatol Venereol; 2008; 135(8-9):580-3. PubMed ID: 18789293
[TBL] [Abstract][Full Text] [Related]
5. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
Webster-Gandy JD; How C; Harrold K
Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced acral erythema (CIAE) with bullous reaction.
Azurdia RM; Clark RE; Friedmann PS
Clin Exp Dermatol; 1999 Mar; 24(2):64-6. PubMed ID: 10233654
[TBL] [Abstract][Full Text] [Related]
7. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Risum S; Langer SW
Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
[TBL] [Abstract][Full Text] [Related]
8. Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.
Tanyi JL; Smith JA; Ramos L; Parker CL; Munsell MF; Wolf JK
Gynecol Oncol; 2009 Aug; 114(2):219-24. PubMed ID: 19446868
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced acral erythema: desquamating lesions involving the hands and feet.
Kroll SS; Koller CA; Kaled S; Dreizen S
Ann Plast Surg; 1989 Sep; 23(3):263-5. PubMed ID: 2528937
[TBL] [Abstract][Full Text] [Related]
10. Images in clinical medicine. Palmar-plantar rash with cytarabine therapy.
Rosenbeck L; Kiel PJ
N Engl J Med; 2011 Jan; 364(3):e5. PubMed ID: 21247311
[No Abstract] [Full Text] [Related]
11. Palmar-plantar erythrodysaesthesia and non-pegylated liposomal doxorubicin. A case study.
Tamayo-Orbegozo E; Iruin-Sanz A; Oñate-Muzás E; Segrelles-Bellmunt G
Farm Hosp; 2011; 35(1):46-7. PubMed ID: 20619714
[No Abstract] [Full Text] [Related]
12. Painful blistered hands and feet.
Coyle C; Wenhold V
Clin J Oncol Nurs; 2001; 5(5):230-2. PubMed ID: 11899771
[TBL] [Abstract][Full Text] [Related]
13. Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy.
Cox GJ; Robertson DB
Arch Dermatol; 1986 Dec; 122(12):1413-4. PubMed ID: 2947543
[TBL] [Abstract][Full Text] [Related]
14. Palmar-plantar erythrodysesthesia and cytarabine.
Baer MR; King LE; Wolff SN
Ann Intern Med; 1985 Apr; 102(4):556. PubMed ID: 3977204
[No Abstract] [Full Text] [Related]
15. Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management.
Nagore E; Insa A; Sanmartín O
Am J Clin Dermatol; 2000; 1(4):225-34. PubMed ID: 11702367
[TBL] [Abstract][Full Text] [Related]
16. Acute and painful erythema of the hands and feet. Acral erythema induced by chemotherapy.
Revenga Arranz F; Fernández-Durán DA; Grande C; Rodríguez Peralto JL; Vanaclocha Sebastián F
Arch Dermatol; 1997 Apr; 133(4):499-500, 502-3. PubMed ID: 9126025
[No Abstract] [Full Text] [Related]
17. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur.
Rios-Buceta L; Buezo GF; Peñas PF; Dauden E; Fernandez-Herrera J; Garcia-Diez A
Acta Derm Venereol; 1997 Jan; 77(1):80-1. PubMed ID: 9059693
[No Abstract] [Full Text] [Related]
18. Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin.
Gordinier ME; Dizon DS; Fleming EL; Weitzen S; Schwartz J; Parker LP; Granai CO
Gynecol Oncol; 2006 Oct; 103(1):72-4. PubMed ID: 16494932
[TBL] [Abstract][Full Text] [Related]
19. Palmar-plantar erythema associated with combination chemotherapy.
Pagliuca A; Kaczmarski R; Mufti GJ
Postgrad Med J; 1990 Mar; 66(773):242-3. PubMed ID: 1694580
[TBL] [Abstract][Full Text] [Related]
20. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
Lipworth AD; Robert C; Zhu AX
Oncology; 2009; 77(5):257-71. PubMed ID: 19923864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
